Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tritiated acetylcholine was used to measure binding sites with characteristics of nicotinic cholinergic receptors in rat brain. Regulation of the binding sites in vivo was examined by administering two drugs that stimulate nicotinic receptors directly or indirectly. After 10 days of exposure to the cholinesterase inhibitor diisopropyl fluorophosphate, binding of tritiated acetylcholine in the cerebral cortex was decreased. However, after repeated administration of nicotine for 10 days, binding of tritiated acetylcholine in the cortex was increased. Saturation analysis of tritiated acetylcholine binding in the cortices of rats treated with diisopropyl fluorophosphate or nicotine indicated that the number of binding sites decreased and increased, respectively, while the affinity of the sites was unaltered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown that high-dose chronic and intermittent nicotine exposure increases levels of high-affinity nicotinic receptors in adult humans and rodents (10–14).”
In the citing paper
“Repeated or prolonged nicotine exposure increases the number of high-affinity (mainly α4β2*) nicotine-binding sites, in heterologous systems (41, 42), nicotine-treated animals (11, 12), and in post mortem brains of smokers (ref. 10; for review, see ref. 43).”
In the citing paper
“animals exposed to nicotine chronically exhibit increased levels of nAChRs in the brain (Marks et al., 1983(Marks et al., , 1985(Marks et al., , 1992;;Schwartz and Kellar, 1983)”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“A hallmark of chronic nicotine administration is the upregulation of nicotinic receptors in the brain (Marks et al, 1983; Schwartz and Kellar, 1983) and recent studies in humans have suggested a functional role of these receptors in relapse vulnerability (Cosgrove et al, 2009).”
From Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal (2013) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“Chronic nicotine administration increases ␣42 neuronal nicotinic acetylcholine receptor (nAChR) density in brain.”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Schwartz and Kellar, 1983
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Muscarinic Cholinergic Binding in Rat Brain
Yamamura, H. I., & Snyder, S. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1725 · Cited by 1,203
Annual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Stereospecific Nicotine Receptors on Rat Brain Membranes
Romano, C., & Goldstein, A. (1980) · Science · doi:10.1126/science.7433991 · Cited by 319
Receptor Adaptations to Centrally Acting Drugs
Creese, I., & Sibley, D. R. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002041 · Cited by 290
THESLEFF, S. (1955) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1955.tb01242.x · Cited by 281
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
Schwartz, R. D., McGee, R., & Kellar, K. J. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15102-x · Cited by 261
Self-citationNicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
Tripathi, H. L., Martin, B. R., & Aceto, M. D. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33022-3 · Cited by 171
The action potential of the superior cervical ganglion
Eccles, J. C. (1935) · The Journal of Physiology · doi:10.1113/jphysiol.1935.sp003313 · Cited by 165
Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions
McKinney, M., & Coyle, J. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-01-00097.1982 · Cited by 156
Research works printed but not linked: 2
- DALE, H.H., J PHARMACOL EXP THER 6: 174 (1914).
- PORSIUS, A. J., ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 28: 1628 (1978).
Cited by
Items 201–300 of 481
Lebargy, F., Benhammou, K., Morin, D., Zini, R., Urien, S., Brée, F., Bignon, J., Branellec, A., & Lagrue, G. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.3.8630545 · Cited by 41
Rosecrans, J. A., & Karan, L. D. (1993) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(93)90041-y · Cited by 47
Beerepoot, P., Nazari, R., & Salahpour, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.036 · Cited by 42
Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease
Takakubo, F., Yamamoto, M., Ogawa, N., Yamashita, Y., Mizuno, Y., & Kondo, I. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273362 · Cited by 41
Subchronic treatment of rats with nicotine: Interconversion of nicotinic receptor subtypes in brain
Romanelli, L., Öhman, B., Adem, A., & Nordberg, A. K. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90577-8 · Cited by 40
Metaxas, A., Bailey, A., Barbano, M. F., Galeote, L., Maldonado, R. J., & Kitchen, I. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00246.x · Cited by 44
“The observation that the administration of nicotine leads to increased brain nAChR density in cigarette smokers (Perry et al. 1999) and in animal models of nicotine consumption (Marks, Burch & Collins 1983; Schwartz & Kellar 1983) constitutes the hallmark of chronic nicotine exposure.”
BackgroundResultGoldberg, L. R., Zeid, D., Kutlu, M. G., Cole, R. D., Lallai, V., Sebastian, A., Albert, I., Fowler, C. D., Parikh, V., & Gould, T. J. (2021) · Addiction Biology · doi:10.1111/adb.12859 · Cited by 39
“These data are in line with previous findings of upregulated high‐affinity nAChR binding following decreased nAChR function.(49) Because both potassium‐evoked and nicotine‐evoked ACh release were altered in the vHPC of NIC‐Sired mice, vHPC may be more sensitive to the multigenerational effects of paternal nicotine exp…”
ResultCaggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Knopf, S., Perkins, K. A., & Stiller, R. L. (1993) · Psychopharmacology · doi:10.1007/bf02253543 · Cited by 40
Chronic treatments with cholinoceptor drugs influence spatial learning in rats
Abdulla, F. A., Calaminici, M., Stephenson, J., & Sinden, J. D. (1993) · Psychopharmacology · doi:10.1007/bf02253544 · Cited by 41
“Chronic treatment with DFP, on the other hand, induced down-regulation in both muscarinic and nicotinic cortical receptors ( Schwartz and Kellar 1983 ) and down-regulation in hippocampal and striatal muscarinic receptors (Schiller 1979).”
BackgroundNicotine binding to brain tissue from drug-naive and nicotine-treated rats
Benwell, M. E. M., & Balfour, D. J. K. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb03024.x · Cited by 38
Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37
Self-citationMarks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R., McIntosh, J. M., & Whiteaker, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12721 · Cited by 36
Targeting Nicotinic Receptors for Parkinson's Disease Therapy
Quik, M., Bordia, T., Huang, L. Z., & Perez, X. A. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711797247849 · Cited by 41
Gu, S., Knowland, D., Matta, J. A., O’Carroll, M. L., Davini, W. B., Dhara, M., Kweon, H.-J., & Bredt, D. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013762117 · Cited by 40
Engeland, C. G., Mahoney, C., Mohr, E., Ilivitsky, V., & Knott, V. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00711-6 · Cited by 40
Dickson, P. E., Miller, M. M., Rogers, T. D., Blaha, C. D., & Mittleman, G. (2014) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00496.x · Cited by 35
“Nicotine-induced upregulation in nAChRs is a wellknown consequence of nicotine exposure in rats (Schwartz & Kellar 1983, 1985; Webster et al. 1999), mice (Marks, Burch & Collins 1983; Marks et al. 1992) and humans (Perry et al. 1999).”
BackgroundHussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
“Specifically, chronic administration of nicotine increases nAChRs in rat and mouse brain (Marks et al., 1983; Schwartz and Kellar, 1983), and a similar increase is found in autopsied brains from smokers (Benwell et al., 1988; Breese et al., 1997; Perry et al., 1999).”
InfluentialSelf-citationHypersensitive knockin mouse strains identify receptors and pathways for nicotine action.
Lester, H. A., Fonck, C., Tapper, A. R., McKinney, S. L., Damaj, M. I., Balogh, S. A., Owens, J. C., Wehner, J. M., Collins, A. C., & Labarca, C. G. (2003) · PubMed · Cited by 36
Knott, V., Millar, A., Fisher, D. J., & Albert, P. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.053 · Cited by 36
Chapter 14 Effect of nicotine on the release of acetylcholine and amino acids in the brain
Beani, L., Bianchi, C., Ferraro, L., Nilsson, L. M., Nordberg, A. K., Romanelli, L., Spalluto, P., Sundwall, A., & Tanganelli, S. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62474-7 · Cited by 34
Alteration of nicotinic cholinergic agonist binding sites in hippocampus after fimbria transection
Morrow, A. L., Loy, R., & Creese, I. (1985) · Brain Research · doi:10.1016/0006-8993(85)90223-9 · Cited by 34
Marks, M. J., Meinerz, N. M., Brown, R. W. B., & Collins, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.040 · Cited by 34
“Chronic exposure to nicotine increases the numbers of α4β2*-nAChR in brain of rodents [17-19,40-43] humans [44-46] and cell lines [47-49].”
BackgroundPalmitoylation of Nicotinic Acetylcholine Receptors
Alexander, J. K., Govind, A. P., Drisdel, R. C., Blanton, M. P., Vallejo, Y., Lam, T. T., & Green, W. N. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9246-z · Cited by 34
“Nicotine-induced upregulation is observed in vivo and linked to nicotine addiction (Marks et al. 1983; Schwartz and Kellar 1983; Benwell et Figure 1 Palmitoylation of muscle nAChRs. a The palmitoylation sites of Torpedo nAChRs purified from electric organ membranes were labeled with biotin-BMCC…”
Dau, A., Komal, P., Truong, M., Morris, G., Evans, G., & Nashmi, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-47 · Cited by 43
“The majority of studies on nicotine-mediated nAChR upregulation have focused on the chronic effects of agonists or antagonists, mainly on time frames of 24 hrs to a few days in cell and neuronal culture [1-4,9-11], 10 to 30 days for chronic nicotine exposure in rodents [6,7,36,49] and many years in smokers’ brains [8,…”
BackgroundElsonbaty, S. M., & Ismail, A. F. M. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108382 · Cited by 32
Wilkinson, D. S., Turner, J. R., Blendy, J. A., & Gould, T. J. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2808-8 · Cited by 32
“Previous findings have shown that chronic nicotine upregulates nicotinic acetylcholine receptors (nAChRs) in the brain (Marks et al. 1983a; Schwartz and Kellar 1983), which return to control levels as the duration of withdrawal increases (Marks et al.”
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Schmidt, H. D., Rupprecht, L. E., & Addy, N. (2018) · Complex Psychiatry · doi:10.1159/000494799 · Cited by 36
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 40
“No generalized role for these receptors in central synaptic transmission can be ascribed; in the CNS they are present and function at postsynaptic [80,81] and presynaptic sites [for review see 82].”
BackgroundInfluentialRasmussen, B. A., & Perry, D. C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.010 · Cited by 33
In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisine
Flesher, J. E., Scheffel, U., London, E. D., & Frost, J. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90146-5 · Cited by 32
Henningfield, J. E., & Zeller, M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0308-4 · Cited by 32
Renda, A., & Nashmi, R. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-89 · Cited by 35
“Nicotine provides positive reinforcement by activating α4-containing (α4*) and β2-containing (β2*) nAChRs in the ventral tegmental area [3-5,14,15] and chronic administration of nicotine upregulates high-affinity α4β2 nAChR expression in mice [6,7,16] and rats [17], altering the molecular circuitry that governs reward.”
Fisher, M. L., LeMalefant, R., Zhou, L., Huang, G., & Turner, J. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.257 · Cited by 33
“Upregulation of nAChRs, a hallmark of nicotine treatment (Schwartz and Kellar, 1983), was observed in nicotine-treated animals.”
BackgroundPharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach
Schuster, C. R., & Kuhar, M. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3 · Cited by 33
Potter, A., Ryan, K. K., & NEWHOUSE, P. A. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1026 · Cited by 33
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript (Schwartz and Kellar, 1983, 1985), there may be downstream accommodations in neural systems that receive nicotinic innervation, which would result in tolerance to the cognitive effects of nicotine.”
BackgroundStone, J. D., Terry, A. V., Pauly, J. R., Prendergast, M., & Buccafusco, J. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02689-5 · Cited by 31
Is Binding to Nicotinic Acetylcholine and Dopamine Receptors Related to Working Memory in Rats?
Levin, E. D., Torry, D. J., Christopher, N. C., Yu, X., Einstein, G., & Schwartz‐Bloom, R. D. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00009-9 · Cited by 31
Control of receptor sensitivity at the mRNA level
Morris, B. (1993) · Molecular Neurobiology · doi:10.1007/bf02769175 · Cited by 30
Tolerance to nicotine's effects on striatal dopamine metabolism in nicotine-withdrawn mice
Pietilä, K., Salminen, O., Leikola‐Pelho, T., & Ahtee, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00767-4 · Cited by 32
Larsson, C. U., Nilsson, L. M., Halén, A., & Nordberg, A. K. (1986) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(86)90034-7 · Cited by 31
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29
Kamens, H. M., McKinnon, C. S., Li, N., Helms, M. L., Belknap, J. K., & Phillips, T. J. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00444.x · Cited by 31
“This would be consistent with the work of Schwartz and Kellar (1983) who showed that treatment with a cholinesterase inhibitor, which had the effect of increasing acetylcholine levels, decreased nAChR levels.”
ResultHosur, V., Leppanen, S., Taha, A. A., & Loring, R. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06373.x · Cited by 30
Kellar, K. J., Giblin, B. A., & Lumpkin, M. D. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62480-2 · Cited by 30
Self-citationJanson, A. M., Hedlund, P. B., Fuxé, K., & von Euler, G. (1994) · Brain Research · doi:10.1016/0006-8993(94)91593-8 · Cited by 30
Heterogenous Cholinergic Nicotinic Receptors in the CNS
Nordberg, A. K., Adem, A., Nilsson, L. M., Romanelli, L., & Zhang, X. L. (1988) · Springer eBooks · doi:10.1007/978-3-642-74167-8_24 · Cited by 30
Biochemistry of Nicotinic Acetylcholine Receptors in the Vertebrate Brain
Schmidt, J. (1988) · International review of neurobiology · doi:10.1016/s0074-7742(08)60045-8 · Cited by 31
Dávila-Garcı́a, M. I., Houghtling, R. A., Qasba, S. S., & Kellar, K. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00344-1 · Cited by 28
Self-citationCooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 32
“Nicotine-induced upregulation of α4β2* nAChRs has been shown to depend on the specific subunit composition, with the high-sensitivity stoichiometry to be favored [35,37,80,88].”
BackgroundPharmacological approaches to smoking cessation
Mitrouska, I., Bouloukaki, I., & Siafakas, N. M. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.10.012 · Cited by 40
“Unlike most agonists, which downregulate receptor numbers with chronic exposure , chronic administration of nicotine leads to desensitization and inactivation of nAChRs, and a paradoxical upregulation of nAChR sites [23] [24] [25] [26].”
BackgroundGupta, R. C., & Dettbarn, W. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90260-7 · Cited by 28
INTERACTION OF CHOLINE WITH NICOTINIC AND MUSCARINIC CHOLINERGIC RECEPTORS IN THE RAT BRAIN IN VITRO
Costa, L. G., & Murphy, S. D. (1984) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1984.tb00878.x · Cited by 28
The effect of chronic nicotine treatment on nicotine-induced seizures
Miner, L. L., & Collins, A. C. (1988) · Psychopharmacology · doi:10.1007/bf00212766 · Cited by 33
“Increased brain nicotinic receptor concentrations have been observed following chronic nicotine treatment in several other studies (Schwartz and Kellar 1982; Ksir et al. 1985; Marks and Collins 1985; Morrow et al. 1985; Marks et al. 1986) and these changes in binding correlate with a decrease in behavioral responsiven…”
BackgroundLeitzke, M. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00104-7 · Cited by 29
“Nicotine effect on the nicotinic acetylcholine receptors The chronic application of nicotine in animal and in vitro models yielded an up-regulation (Buisson and Bertrand 2001) of respective central binding sites, whereas the chronic increase of the natural ligand ACh via application of a cholinesterase inhibitor led t…”
BackgroundThe mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity α4β2 nAChRs
Kim, H., Flanagin, B. A., Qin, C., Macdonald, R. L., & Stitzel, J. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00167-9 · Cited by 29
“receptors (Schwartz and Kellar, 1983; Marks et al., 1983).”
Kozikowski, A. P., Chellappan, S. K., Xiao, Y., Bajjuri, K. M., Yuan, H., Kellar, K. J., & Petukhov, P. A. (2007) · ChemMedChem · doi:10.1002/cmdc.200700073 · Cited by 31
Self-citationAcute Nicotine Administration in Alzheimer’s Disease: An Exploratory EEG Study
Knott, V., Engeland, C. G., Mohr, E., Mahoney, C., & Ilivitsky, V. (2000) · Neuropsychobiology · doi:10.1159/000026662 · Cited by 27
Evaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging
Kant, R., Constantinescu, C. C., Parekh, P. K., Pandey, S. K., Pan, M., Easwaramoorthy, B., & Mukherjee, J. (2011) · EJNMMI Research · doi:10.1186/2191-219x-1-6 · Cited by 28
“Studies have also shown an increase in a4b2 receptor density binding sites in rat and mice brains upon exposure to nicotine [ 8-10 ].”
BackgroundBordia, T., Parameswaran, N., Fan, H. S., Langston, J. W., McIntosh, J. M., & Quik, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106997 · Cited by 28
“These receptor declines after nigrostriatal damage contrast with the effects of nicotine treatment, which typically increases high-affinity 4 2* nAChRs in unlesioned animal models (Marks et al., 1983; Schwartz and Kellar, 1983).”
BackgroundBrain nicotinic cholinoceptor binding in spontaneous hypertension
Yamada, S., Kagawa, Y., Ushijima, H., Takayanagi, N., Tomita, T., & Hayashi, E. (1987) · Brain Research · doi:10.1016/0006-8993(87)90318-0 · Cited by 26
Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear
Gould, T. J., Wilkinson, D. S., Yildirim, E., Blendy, J. A., & Adoff, M. D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.038 · Cited by 28
“At the level of the receptor, chronic nicotine is associated with desensitization and upregulation (Hulihan-Giblin et al., 1990; Marks et al., 1983; Schwartz and Kellar, 1983; Sharp and Beyer, 1986).”
BackgroundMorganstern, I., Lukatskaya, O., Moon, S.-H., Guo, W.-R., Shaji, J., Karatayev, O., & LEIBOWITZ, S. F. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3178-6 · Cited by 27
“…previously in adult rats with chronic nicotine exposure (Flores et al. 1997; Mugnaini et al. 2002; Parker et al. 2004; Rasmussen and Perry 2006; Schwartz and Kellar 1983) or high-fat diet consumption (Morganstern et al. 2012) and also in offspring exposed prenatally to nicotine (Shacka and…”
NACHO Engages N-Glycosylation ER Chaperone Pathways for α7 Nicotinic Receptor Assembly
Kweon, H.-J., Gu, S., Witham, E. A., Dhara, M., Yu, H. Y., Mandon, E. D., Jawhari, A., & Bredt, D. S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108025 · Cited by 29
Nicotinic Agonists Regulate α‐Bungarotoxin Binding Sites of TE671 Human Medulloblastoma Cells
Siegel, H. N., & Lukas, R. J. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10604.x · Cited by 25
Nicotine Receptors in the Central Nervous System
Martin, B. R. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-185203-0.50018-5 · Cited by 25
DeDominicis, K. E., Sahibzada, N., Olson, T. T., Xiao, Y., Wolfe, B. B., Kellar, K. J., & Yasuda, R. P. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106880 · Cited by 25
“…system physiology, considerable evidence points to the involvement of these receptors in nicotine addiction and dependence (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988; Flores et al., 1992, 1997; Perry et al., 1999; Staley et al., 2006; Wüllner et al., 2008; Marks et…”
BackgroundSelf-citationDomino, E. F., Mirzoyan, D., & Tsukada, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.024 · Cited by 29
Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease
Ksir, C. J., & Benson, D. M. (1983) · Psychopharmacology · doi:10.1007/bf00427277 · Cited by 24
“Schwartz and Kellar (1983) have recently developed a technique for measuring specific nicotinic binding, and have found both increases and decreases in response to chronic drug administration.”
Madhok, T. C., Matta, S. G., & Sharp, B. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00073-2 · Cited by 27
Rosecrans, J. A. (1995) · Behavior Genetics · doi:10.1007/bf02196927 · Cited by 27
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 24
“Treatment with nicotine consistently increases the density of nAChRs in rat and mouse cerebral cortex (Schwartz and Kellar 1983; Marks et al. 1983).”
Self-citationWecker, L., Pollock, V. V., Pacheco, M. A., & Pastoor, T. E. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.005 · Cited by 27
“…receptors (Pacheco et al., 2001), following injection of subunit mRNAs into Xenopus laevis oocytes (Fenster et al., 1999), and in brain from rats (Schwartz and Kellar, 1983), mice Correspondence should be addressed to: Lynn Wecker, Ph.D., USF Department of Psychiatry and Behavioral Medicine,…”
Chronic treatment with varenicline changes expression of four nAChR binding sites in mice
Marks, M. J., O’Neill, H. C., Wynalda, K., Ortiz, N. C., Simmons, E. E., Short, C. A., Butt, C. M., McIntosh, J. M., & Grady, S. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.019 · Cited by 25
“Increases in the most widely expressed nAChR subtype (a4b2*-nAChR) occurs in mouse, rat and human brain following exposure to nicotine (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988; Perry et al., 1999; Marks et al., 2011).”
InfluentialNicotine's effect on neural and cognitive functioning in an aging population
Murray, K. N., & Abeles, N. (2002) · Aging & Mental Health · doi:10.1080/13607860220126808 · Cited by 28
“Previous studies have shown dramatic increases in NAChRs in the brains of mice and rats exposed to nicotine (Marks, Burch & Collins, 1983; Schwartz & Kellar, 1983), as well as studies hinting at increased receptors in humans (Benwell, Balfour & Anderson, 1988).”
BackgroundLim, D. K., Hoskins, B., & Ho, I. K. (1987) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(87)90139-6 · Cited by 23
Leone, F. T., Carlsen, K., Folan, P. A., Latzka, K., Munzer, A., Neptune, E., Pakhale, S. S., Sachs, D. P. L., Samet, J. M., Upson, D. J., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1081st · Cited by 25
Rassoulpour, A., Wu, H., Albuquerque, E. X., & Schwarcz, R. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300583 · Cited by 23
“Thus, nAChRs show both desensitization (Marks et al, 1983; Castro and Albuquerque, 1995) and subsequent supersensitivity (Schwartz and Kellar, 1983, 1985; Wonnacott et al, 1990) in response to repeated or chronic nicotine treatment, and these adaptive changes may influence the nAChRs-mediated…”
BackgroundEffects of mescaline and some of its analogs on cholinergic neuromuscular transmission
Ghansah, E., Kopsombut, P., Maleque, M. A., & BROSSI, A. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90097-m · Cited by 22
Chronic nicotine-induced improvement of spatial working memory and D2 dopamine effects in rats
Levin, E. D., Christopher, N. C., Briggs, S. J., & Auman, J. T. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(19960901)39:1<29::aid-ddr4>3.0.co;2-m · Cited by 19
Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain
Nilsson-Håkansson, L., Lai, Z., & Nordberg, A. K. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90448-f · Cited by 22
Nicotinic Receptors and Cholinergic Neurotransmission in the Central Nervous System
Clarke, P. B. S. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17465.x · Cited by 26
Nicotine Self-Administration Induces Plastic Changes to Nicotinic Receptors in Medial Habenula
Jin, X., Tucker, B. R., & Drenan, R. M. (2020) · eNeuro · doi:10.1523/eneuro.0197-20.2020 · Cited by 24
“, 2006), rodents (Marks et al., 1983; Schwartz and Kellar, 1983), non-human primates (McCallum et al.”
BackgroundInfluentialPotter, P. E., Hadjiconstantinou, M., Rubenstein, J. S., & Neff, N. H. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90065-7 · Cited by 21
Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine
Harris, A. C., Manbeck, K. E., Schmidt, C. E., & Shelley, D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2814-x · Cited by 24
Abdulla, F. A., Calaminici, M., Wonnacott, S., Gray, J. A., Stephenson, J. D., & Sinden, J. D. (1995) · Synapse · doi:10.1002/syn.890210402 · Cited by 21
“The possibility that chronic nicotine affects these muscarinic mechanisms is unlikely, although reported effects of chronic nicotine administration on muscarinic receptors are inconsistent (Lapchak et al., 1989; Marks et al., 1985; Schwartz and Kellar, 1983; Yamanaka et al., 1985, 1987).”
BackgroundShort- and Long-Lasting Consequences of In Vivo Nicotine Treatment on Hippocampal Excitability
Penton, R. E., Quick, M. W., & Lester, R. A. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4362-10.2011 · Cited by 19
“…no effect on excitatory synaptic transmission in hippocampal slices from saline-treated animals, it is plausible that the in vitro homeostatic effects are the result of nicotine interacting with nAChRs upregu- lated by the in vivo nicotine exposure (Marks et al., 1983; Schwartz and Kellar, 1983).”
BackgroundInfluentialJia, L., Flotildes, K., Li, M., & Cohen, B. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01578.x · Cited by 20
Aging, Smoking and EEG Coherence: A Preliminary Study
Knott, V., & Harr, A. (1997) · Clinical Electroencephalography · doi:10.1177/155005949702800409 · Cited by 19
Kiritsy‐Roy, J. A., Mousa, S. A., Appel, N. M., & Loon, G. R. V. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90071-x · Cited by 21
Yu, K., Liu, Q., Wu, J., & Lukas, R. J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.48 · Cited by 23
Discriminative Stimulus (DS) Properties of Nicotine in the C57BL/6 Mouse
Varvel, S. A., James, J. R., Bowen, S. E., Rosecrans, J. A., & Karan, L. D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00262-7 · Cited by 19
Vigé, X., & Briley, M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90231-5 · Cited by 18
Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
Siraki, A. G., Chevaldina, T., Moridani, M. Y., & O'Brien, P. J. (2004) · PubMed · Cited by 18
Nicotine-related brain disorders: The neurobiological basis of nicotine dependence
Ochoa, E. L. M. (1994) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088321 · Cited by 22
“Down-regulation of central and peripheral nAChRs exists after chronic treatment of rats with cholinesterase inhibitors (Schwartz and Kellar, 1983, 1985) or after chronic administration of nicotine (Robinson and McGee, 1985; Berg et al., 1989; Lukas and Bencherif, 1992, and references therein),…”
BackgroundHenley, J. M., & Oswald, R. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48297-x · Cited by 18
Tilson, H. A., Schwartz, R. D., Ali, S. F., & McLamb, R. L. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90178-0 · Cited by 18
Self-citationThe Effect of Acute Dyflos (DFP) Treatment on [3H]Nicotine Binding to Mouse Brain Homogenate
Scimeca, J. A., & Martin, B. R. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05174.x · Cited by 18
Cano, M., Reynaga, D. D., Belluzzi, J. D., Loughlin, S. E., & Leslie, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108308 · Cited by 17
Hoegberg, B. G., Lomazzo, E., Lee, N. H., & Perry, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.015 · Cited by 17
“Chronic administration of nicotine increases the density of nAChRs in rat and mouse brains (Schwartz and Kellar, 1983; Marks et al., 1983).”
BackgroundCollins, A. C., Marks, M. J., & Pauly, J. R. (1989) · Journal of Substance Abuse · doi:10.1016/s0899-3289(18)30004-x · Cited by 17
Metadata
- Authors
- Schwartz, R. D., & Kellar, K. J.
- Affiliations
- Georgetown University (US)
- ORCID
- Kellar, Kenneth J.
- Venue
- Science
- Published
- 1983-04-08
- Volume
- 220
- Issue
- 4593
- Pages
- 214-216
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2091374932
- Cited by
- 479
- References
- 17
- Citations by year
- 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 3 · 2020: 14 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 11 · 2015: 12 · 2014: 13 · 2013: 17 · 2012: 19
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor binding sites, diisopropylfluorophosphate, nicotine, cholinesterase inhibition, cerebral cortex, receptor regulation, receptor density, receptor binding affinity, saturation analysis
- MeSH terms
- Acetylcholine, Animals, Brain, Brain Chemistry, Cerebral Cortex, Isoflurophate, Male, Nicotine, Rats, Inbred Strains, Receptors, Cholinergic, Receptors, Nicotinic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.